Eurofarma's Hospitalar unit supplying hospital medicines and large-volume parenteral solutions, including anesthetics, to Brazilian hospitals.
Eurofarma's Hospitalar business unit supplies medicines and large-volume parenteral solutions to the Brazilian hospital market, with an explicit anesthetics class in its portfolio. The unit reports 1,645 active hospital clients and a searchable hospitalar product line on Eurofarma's official site.
It competes directly with Cristália's Hospital Anesthetics & Hospital Injectables line for hospital and ICU formulary placements in Brazil.
| Attribute | Hospital Medicines & Large-Volume Parenteral Solutions | Hospital Anesthetics & Hospital Injectables | |
|---|---|---|---|
| Provider | |  | |
| Founded | 1972 | 1972 | |
| Sells To | Consumers | Consumers, Hospitals | |
| Pricing Model | Recurring, Software, Transactional | Product Sales | |
| Ownership | Public | Private |
Provider
Founded 1972
Sells To Consumers
Pricing Model Recurring, Software, Transactional
Ownership Public
Provider
Founded 1972
Sells To Consumers, Hospitals
Pricing Model Product Sales
Ownership Private
Blau FarmacêuticaBlau Farmacêutica's institutional line of hospital injectables and injectable anesthetics, serving hospitals across Brazil and the SUS system.
Hypofarma's injectable portfolio of anesthetics and hospital injectables, including hyperbaric bupivacaine, ropivacaine, and ICU ampoules.
EMS's hospital unit supplying medicines and solutions to hospitals and institutional healthcare buyers, reinforced by a 2026 injectables acquisition.
Farma is Cristália's retail prescription-medicines portfolio spanning pain, mental health, dermatology, oncology, and endocrinology.
Blau Farmacêutica's institutional line of hospital injectables and injectable anesthetics, serving hospitals across Brazil and the SUS system.
Blau FarmacêuticaHypofarma's injectable portfolio of anesthetics and hospital injectables, including hyperbaric bupivacaine, ropivacaine, and ICU ampoules.
EMS's hospital unit supplying medicines and solutions to hospitals and institutional healthcare buyers, reinforced by a 2026 injectables acquisition.
Farma is Cristália's retail prescription-medicines portfolio spanning pain, mental health, dermatology, oncology, and endocrinology.